Humimic Biosystems has developed a comprehensive suite of innovative organ-on-chip technologies, built to provide more human-relevant data earlier in the drug development process.

 

We help to identify ineffective drug candidate compounds before expensive animal and human trials, helping bring drugs to market two years faster and for $250 million less.